| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 1e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |